The administration of President Donald Trump has pledged to invest US $ 1.2 billion in AstraZeneca. In return, the British pharmaceutical company will provide 300 million doses of vaccine against Covid-19 to the United States.
According to Bloomberg, the US Department of Health announced that it will invest US $ 1.2 billion to support British pharmaceutical firm AstraZeneca to accelerate development of a new strain of corona virus vaccine. In return, AstraZeneca will provide 300 million vaccines to the United States.
“The contract with AstraZeneca is a milestone in the government’s campaign to ensure a safe and effective supply of vaccines by 2021,” US Health Secretary Alex Azar said.
The vaccine, called AZD1222, was studied and licensed for production by AstraZeneca. Under an agreement between the US Department of Health and AstraZeneca, the final phase test will be conducted with 30,000 people in the United States.
AstraZeneca says it has the capacity to produce 1 billion doses of vaccine. Earlier, the company pledged to provide 100 million doses to the people of England. The London government has also promised its people that they will get the first vaccine.
Currently, governments and pharmaceutical companies are studying dozens of corona virus vaccines. Experts estimate that it takes 12-18 months to develop a safe and effective vaccine.
Inovio Pharmaceuticals, Inc., announced its experimental vaccine produces antibodies in mice and guinea pigs. Earlier this week, Moderna announced that the company’s testing also yielded positive results.